Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compound for inhibiting PGE2/EP4 signaling transduction inhibiting, preparation method therefor, and medical uses thereof

Compound for inhibiting PGE2/EP4 signaling transduction inhibiting, preparation method therefor, and medical uses thereof

US Patent 12240812 · Granted Mar 4, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sulfonylamidine substituted compounds and their use as beta-lactamase inhibitors2025
Method for manufacturing TFT substrate and TFT substrate thereof2025
Substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (IDO) in2025
Substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (IDO) in2024
Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors2021
Substituted n′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,2021
Optimized in vivo delivery system with endosomolytic agents for nucleic acid con2020
Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors2020
Compounds as indoleamine 2,3-dioxygenase inhibitors2020
Optimized in vivo delivery system with endosomolytic agents for nucleic acid con2019
Geminally substituted cyanoethylpyrazolo pyridones as Janus kinase inhibitors2018
Purine inhibitors of human phosphatidylinositol 3-kinase delta2018